Sertraline in the treatment of premature ejaculation: a double-blind placebo controlled study

This study investigated the efficacy and the adverse effects of sertraline in the treatment of premature ejaculation (PE). Thirty-seven patients with PE were randomly assigned to receive either sertraline or a placebo. Of them 22 were given 50 mg of sertraline per day and the other 15 patients were...

Full description

Saved in:
Bibliographic Details
Published in:International urology and nephrology 1998, Vol.30 (5), p.611-615
Main Authors: Biri, H, Isen, K, Sinik, Z, Onaran, M, Küpeli, B, Bozkirli, I
Format: Article
Language:English
Subjects:
Adult
Double-Blind Method
Ejaculation - drug effects
Evaluation Studies as Topic
Humans
Male
Middle Aged
Serotonin Uptake Inhibitors - adverse effects
Serotonin Uptake Inhibitors - therapeutic use
Sertraline - adverse effects
Sertraline - therapeutic use
Sexual Dysfunction, Physiological - drug therapy
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study investigated the efficacy and the adverse effects of sertraline in the treatment of premature ejaculation (PE). Thirty-seven patients with PE were randomly assigned to receive either sertraline or a placebo. Of them 22 were given 50 mg of sertraline per day and the other 15 patients were given an identical placebo one per day. After 4 weeks, the latency to ejaculation in the sertraline group was found to be significantly longer than that of the placebo group (p
ISSN:0301-1623
1573-2584
DOI:10.1007/BF02550555